No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 1.5x · 10Y median 1.5x · 52nd percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 16
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T15:06:00.306Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T15:06:00.306Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T15:06:00.306Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T15:06:00.306Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T15:06:00.306Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T15:06:00.306Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T15:06:00.306Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for The Baldwin Insurance Group, Inc. (BWIN) stock was $31.88 as of Oct 6, 2026, 11:05 AM EDT, down 0.08% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +10.7%
Operating across the United States, The Baldwin Insurance Group, Inc. is an independent firm dedicated to providing insurance and comprehensive risk management services.
Insurance - Brokers · Tampa, FL
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Nov 3, 2026
28 days away
EPS Estimate
0.43
Revenue Est.
$492.65M
Last Quarter Results
EPS
$0.48
vs Estimate
$0.47
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1BWIN | $2.58B | $31.88 | -0.08% | +10.71% | N/A | N/A | N/A |
| 2MBINM | $2.54B | $25.43 | +0.04% | +10.83% | N/A | N/A | vs BWIN |
| 3NBTB | $2.65B | $50.89 | -0.12% | +26.90% | +10.28% | +7.51% | vs BWIN |
| 4CLBK | $2.51B | $11.25 | -0.67% | +67.66% | +5.66% | N/A | vs BWIN |
| 5FRME | $2.51B | $39.99 | +0.55% | +8.63% | +2.27% | +7.20% | vs BWIN |
| 6FBNC | $2.51B | $60.68 | -1.80% | +19.98% | +9.41% | +14.07% | vs BWIN |
forward FY estimate
15.84
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$492.94M
vs Estimate
$492.33M
Consensus Rating
Based on 6 analysts
Average Price Target
$32.92
+3.3% upside
Low
$31.00
Current
$31.88
High
$37.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.40 | $0.43 | $0.46 | 7 |
| Quarter ending Dec 2026 | $0.42 | $0.46 | $0.50 | 6 |
| Quarter ending Mar 2027 | $0.76 | $0.79 | $0.82 | 2 |
| Quarter ending Jun 2027 | $0.56 | $0.58 | $0.60 | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $1.96 | $2.01 | $2.06 | 6 |
| FY 2027 | $2.28 | $2.48 | $2.73 | 6 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $485.85M | $492.65M | $498.61M | 4 |
| Quarter ending Dec 2026 | $473.71M | $490.86M | $501.35M | 4 |
| Quarter ending Mar 2027 | $563.74M | $582.27M | $596.63M | 2 |
| Quarter ending Jun 2027 | $523.98M | $541.20M | $554.55M | 2 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $1.99B | $2.01B | $2.03B | 6 |
| FY 2027 | $2.14B | $2.20B | $2.23B | 6 |
